## Abstract Mutation of __PIK3CA__, the gene coding for the p110α catalytic subunit of phosphoinositide 3‐kinase (PI3K), has been reported in a limited range of human tumors. We now report that __PIK3CA__ is also mutated in esophageal tumors. Single‐strand conformational polymorphism (SSCP) and den
PIK3CA cancer mutations display gender and tissue specificity patterns
✍ Scribed by Silvia Benvenuti; Milo Frattini; Sabrina Arena; Carlo Zanon; Vera Cappelletti; Danila Coradini; Maria Grazia Daidone; Silvana Pilotti; Marco A. Pierotti; Alberto Bardelli
- Publisher
- John Wiley and Sons
- Year
- 2008
- Tongue
- English
- Weight
- 155 KB
- Volume
- 29
- Category
- Article
- ISSN
- 1059-7794
No coin nor oath required. For personal study only.
✦ Synopsis
Communicated by Richard
📜 SIMILAR VOLUMES
## Abstract Exome sequencing of human breast cancers has revealed a substantial number of candidate cancer genes with recurring but infrequent somatic mutations. To determine more accurately their mutation prevalence, we performed a mutation analysis of 36 novel candidate cancer genes in 96 human b
## Abstract ## BACKGROUND: AKT (AKT1, AKT2, and AKT3) was a downstream effector of phosphatidylinositide‐3‐kinase (PI3K) and played crucial roles in protein synthesis, cellular metabolism, survival, and proliferation. The PI3K/AKT pathway was commonly activated in human cancers and was recognized